RCC component in thyroid: loss of heterozygosity at VHL locus (3p.25–26) and chromosomal regions 3p, 5q, 14q, and 17qFVPTC component in thyroid: NRAS 61 mutationNo BRAF mutation or RET/PTC rearrangement in any site. Here, BRAF is linked to renal cell carcinoma.